Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL629P is a pseudogene, meaning it is a genomic copy of a functional gene (in this case, the 7SL RNA gene, essential for the signal recognition particle) that has lost its ability to encode a functional product[1][2][5]. Pseudogenes like RN7SL629P are formed by reverse transcription of RNA into DNA, followed by integration into the genome; they often exhibit truncations or sequence differences compared to the original gene[2][5]. RN7SL629P does not produce any protein or RNA known to have biological or pathological activity. Its parent molecule, 7SL RNA, is essential for protein translocation in the signal recognition particle but the pseudogene has no known direct functions or disease associations[3][4]. Summary of key points: - RN7SL629P is a non-functional pseudogene, not a druggable or disease-linked target. - It is important to flag the entry as "is_incorrect: true" in drug or target databases, as pseudogenes like RN7SL629P should not be identified as functional molecular targets for therapy or biomarker development[1][2][5].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 629, pseudogene (RN7SL629P).